SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Form 8.5 (EPT/RI)

3 Feb 2025 11:27

Form 8.5 (EPT/RI)

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeWarpaint London Plc
(c) Name of the party to the offer with which exempt principal trader is connected:Warpaint London Plc
(d) Date dealing undertaken:31 January 2025
(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?Yes – Brand Architekts Group plc

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
OrdinaryPurchases4,563513.2925p510p
OrdinarySales11,049516.475p513.95p

(b) Derivatives transactions (other than option)

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercising

Class of relevant securityProduct description e.g. call optionNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:03 February 2025
Contact name:Justin Ball
Telephone number:0207 647 8130

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
19th Feb 20217:00 amRNSWard & Hagon Contract Renewal
10th Feb 20212:56 pmRNSHolding(s) in Company
22nd Jan 20214:00 pmRNSTransfer of Shares and Director/PDMR Shareholding
18th Jan 20217:00 amRNSFull Year Trading Update
10th Dec 20203:03 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSUK Retail Update
23rd Sep 20207:00 amRNSInterim Results
4th Sep 20207:00 amRNSNotice of Results
16th Jul 20207:00 amRNSChange of Advisers
26th Jun 202012:24 pmRNSResult of AGM
26th Jun 20207:00 amRNSAGM Statement
15th Jun 20207:00 amRNSEquity Development Investor Webinar
1st Jun 20204:36 pmRNSPrice Monitoring Extension
1st Jun 20202:00 pmRNSNotice of AGM and Posting of Annual Report
1st Jun 20207:00 amRNSFurther UK Retail Expansion
21st May 20207:00 amRNSShare Option Plan, Grant of Options & PDMR Holding
13th May 20207:00 amRNSFinal Results for the year ended 31 December 2019
11th May 20204:29 pmRNSHolding(s) in Company
29th Apr 20204:35 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSCovid-19 Update and Notice of Results
19th Mar 20207:00 amRNSUpdate regarding Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSUK Retail Expansion & Trading Update
20th Dec 20197:00 amRNSTrading Update
16th Oct 20194:28 pmRNSDirector Dealings
24th Sep 20197:08 amRNSHolding(s) in Company
20th Sep 20192:25 pmRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
19th Aug 20197:00 amRNSAppointment of Joint Broker
6th Aug 20197:00 amRNSTrading Update and Notice of Results
11th Jun 20197:00 amRNSChange of Adviser
21st May 20191:54 pmRNSHolding(s) in Company
21st May 201911:55 amRNSResult of AGM
21st May 201910:59 amRNSAGM Statement
26th Apr 20192:10 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:13 pmEQSHardman & Co Research: Warpaint London Plc (W7L): FY'18 sales: remains profitable despite weak UK market
10th Apr 20197:00 amRNSResults for the 12 months ended 31 December 2018
3rd Apr 20197:00 amRNSNotice of Results
11th Mar 20193:19 pmRNSHolding(s) in Company
22nd Feb 20194:21 pmRNSHolding(s) in Company
20th Feb 201912:58 pmRNSHolding(s) in Company
29th Jan 20197:00 amRNSTrading Update
1st Nov 201812:45 pmEQSHardman & Co Research: Warpaint London Plc (W7L): Trading update: softening UK market
31st Oct 20187:00 amRNSHolding(s) in Company
30th Oct 201811:52 amRNSDirector Dealings
29th Oct 20189:05 amRNSSecond Price Monitoring Extn
29th Oct 20189:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.